KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Edwards Lifesciences (EW) EBT Margin (2016 - 2025)

Edwards Lifesciences has reported EBT Margin over the past 17 years, most recently at 5.76% for Q4 2025.

  • Quarterly results put EBT Margin at 5.76% for Q4 2025, down 2239.0% from a year ago — trailing twelve months through Dec 2025 was 20.98% (down 748.0% YoY), and the annual figure for FY2025 was 20.98%, down 748.0%.
  • EBT Margin for Q4 2025 was 5.76% at Edwards Lifesciences, down from 22.43% in the prior quarter.
  • Over the last five years, EBT Margin for EW hit a ceiling of 49.17% in Q4 2022 and a floor of 5.76% in Q4 2025.
  • Median EBT Margin over the past 5 years was 29.79% (2024), compared with a mean of 29.47%.
  • Biggest five-year swings in EBT Margin: skyrocketed 5783bps in 2021 and later tumbled -2239bps in 2025.
  • Edwards Lifesciences' EBT Margin stood at 28.3% in 2021, then surged by 74bps to 49.17% in 2022, then tumbled by -41bps to 29.0% in 2023, then decreased by -3bps to 28.15% in 2024, then crashed by -80bps to 5.76% in 2025.
  • The last three reported values for EBT Margin were 5.76% (Q4 2025), 22.43% (Q3 2025), and 26.12% (Q2 2025) per Business Quant data.